LATANOPROST\TIMOLOL: 195 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
195
Total FAERS Reports
23 (11.8%)
Deaths Reported
42
Hospitalizations
195
As Primary/Secondary Suspect
3
Life-Threatening
7
Disabilities
Active Ingredient: LATANOPROST\TIMOLOL MALEATE ·
First Report: 2000 · Latest Report: 20250902
What Are the Most Common LATANOPROST\TIMOLOL Side Effects?
#1 Most Reported
Cataract
37 reports (19.0%)
#2 Most Reported
Glaucoma
20 reports (10.3%)
#3 Most Reported
Vision blurred
15 reports (7.7%)
All LATANOPROST\TIMOLOL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cataract | 37 | 19.0% | 0 | 2 |
| Glaucoma | 20 | 10.3% | 0 | 0 |
| Dizziness | 15 | 7.7% | 1 | 9 |
| Eye irritation | 15 | 7.7% | 0 | 0 |
| Interstitial lung disease | 15 | 7.7% | 15 | 14 |
| Pulmonary hypertension | 15 | 7.7% | 15 | 14 |
| Vision blurred | 15 | 7.7% | 0 | 0 |
| Pneumonitis | 14 | 7.2% | 14 | 13 |
| Drug ineffective | 12 | 6.2% | 0 | 2 |
| Dyspnoea | 11 | 5.6% | 0 | 1 |
| Headache | 11 | 5.6% | 0 | 1 |
| Intraocular pressure increased | 11 | 5.6% | 0 | 0 |
| Visual impairment | 11 | 5.6% | 0 | 0 |
| Arrhythmia | 10 | 5.1% | 0 | 1 |
| Cough | 10 | 5.1% | 0 | 0 |
| Palpitations | 10 | 5.1% | 0 | 0 |
| Febrile neutropenia | 9 | 4.6% | 1 | 1 |
| Off label use | 8 | 4.1% | 1 | 1 |
| Blood pressure increased | 7 | 3.6% | 1 | 1 |
| Bradycardia | 7 | 3.6% | 0 | 7 |
Who Reports LATANOPROST\TIMOLOL Side Effects? Age & Gender Data
Gender: 83.7% female, 16.3% male. Average age: 62.8 years. Most reports from: ES. View detailed demographics →
Is LATANOPROST\TIMOLOL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 2 | 0 | 0 |
| 2002 | 5 | 0 | 0 |
| 2005 | 2 | 0 | 0 |
| 2007 | 1 | 0 | 0 |
| 2008 | 1 | 0 | 0 |
| 2009 | 7 | 0 | 1 |
| 2010 | 2 | 0 | 0 |
| 2011 | 1 | 0 | 0 |
| 2012 | 3 | 0 | 0 |
| 2013 | 4 | 0 | 0 |
| 2014 | 5 | 0 | 0 |
| 2015 | 7 | 0 | 3 |
| 2016 | 5 | 0 | 1 |
| 2017 | 6 | 0 | 2 |
| 2018 | 4 | 0 | 2 |
| 2019 | 4 | 0 | 0 |
| 2020 | 2 | 1 | 1 |
| 2021 | 19 | 16 | 15 |
| 2022 | 4 | 0 | 0 |
| 2023 | 4 | 2 | 0 |
| 2024 | 7 | 0 | 0 |
| 2025 | 2 | 0 | 0 |
What Is LATANOPROST\TIMOLOL Used For?
| Indication | Reports |
|---|---|
| Glaucoma | 66 |
| Product used for unknown indication | 57 |
| Ocular hypertension | 13 |
| Gastrooesophageal reflux disease | 11 |
| Intraocular pressure increased | 9 |
| Immunosuppression | 5 |
LATANOPROST\TIMOLOL vs Alternatives: Which Is Safer?
LATANOPROST\TIMOLOL vs LATISSE
LATANOPROST\TIMOLOL vs LATUDA
LATANOPROST\TIMOLOL vs LAZERTINIB
LATANOPROST\TIMOLOL vs LEBRIKIZUMAB-LBKZ
LATANOPROST\TIMOLOL vs LECANEMAB
LATANOPROST\TIMOLOL vs LECANEMAB-IRMB
LATANOPROST\TIMOLOL vs LECITHIN\POLOXAMER 407
LATANOPROST\TIMOLOL vs LEDIPASVIR
LATANOPROST\TIMOLOL vs LEDIPASVIR\SOFOSBUVIR
LATANOPROST\TIMOLOL vs LEFLUNOMIDE
Official FDA Label for LATANOPROST\TIMOLOL
Official prescribing information from the FDA-approved drug label.